Kailix Advisors LLC reduced its position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) by 12.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,650 shares of the company’s stock after selling 25,800 shares during the quarter. Amrize accounts for approximately 10.8% of Kailix Advisors LLC’s investment portfolio, making the stock its 5th biggest holding. Kailix Advisors LLC’s holdings in Amrize were worth $9,715,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AMRZ. State of Wyoming bought a new stake in Amrize during the third quarter worth $32,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the fourth quarter worth $34,000. US Bancorp DE bought a new stake in Amrize during the third quarter worth $38,000. Costello Asset Management INC bought a new position in shares of Amrize in the third quarter valued at about $44,000. Finally, Global Retirement Partners LLC bought a new position in shares of Amrize in the third quarter valued at about $48,000.
Analyst Ratings Changes
Several equities analysts have recently weighed in on AMRZ shares. Weiss Ratings lowered shares of Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Oppenheimer set a $68.00 price objective on shares of Amrize in a research report on Friday, May 1st. Truist Financial dropped their price objective on shares of Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Citigroup dropped their price objective on shares of Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Finally, Wells Fargo & Company decreased their price target on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $64.50.
Amrize Trading Down 0.1%
AMRZ stock opened at $52.85 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The company’s 50-day simple moving average is $57.20 and its 200 day simple moving average is $55.08. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The company has a market capitalization of $29.23 billion and a PE ratio of 25.29.
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business had revenue of $2.18 billion during the quarter. The business’s quarterly revenue was up 4.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amrize Ltd will post 2.7 earnings per share for the current year.
Amrize Cuts Dividend
The firm also recently declared a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.11 dividend. The ex-dividend date is Tuesday, May 12th.
Insiders Place Their Bets
In other news, CFO Ian A. Johnston acquired 4,250 shares of Amrize stock in a transaction on Tuesday, March 10th. The shares were purchased at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the completion of the purchase, the chief financial officer directly owned 25,110 shares of the company’s stock, valued at approximately $1,479,983.40. This represents a 20.37% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jaime Hill acquired 3,184 shares of Amrize stock in a transaction on Monday, March 9th. The shares were purchased at an average price of $56.34 per share, for a total transaction of $179,386.56. Following the completion of the purchase, the insider directly owned 26,000 shares of the company’s stock, valued at approximately $1,464,840. This represents a 13.96% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 77,836 shares of company stock valued at $4,511,449 in the last three months. Insiders own 0.54% of the company’s stock.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
